We are bringing the practice of pharmacy to clinical trials through our AI-enabled technology allowing everyone everywhere the opportunity to participate in clinical trials, especially underrepresented populations.
RxE2 Progress:
1. We had $0.2M in sales in 2022. We are already over $1.0M in revenue for 2023 and plan to finish over $1.4M for the year. We are projecting revenue of $5M for 2024, positioning us well for our Series A late next year.
2. To achieve our revenue projections for 2024, I brought in a new VP of BD and Sales. I also brought on board a fractional CFO as we continue to move forward on all fronts: Product/Sales/Operations
3. We found our lead investor for our $5M Seed-2 round: O’Leary Ventures ($2.5M investment). Other investors added $1.5M for a total of $4.0M. I am now looking for additional investors to close out the round.
4. With our Seed-2 raise we have the monies we need to get us to Series A in 4Q23 and a clear path to profitability.
Please let me when you we can set up a quick Zoom call.
Ready to Ask For Funding for your company?
Post a Funding Request